Registro completo |
Provedor de dados: |
BJPS
|
País: |
Brazil
|
Título: |
1,3,4-Thiadiazole and 1,2,4-triazole-3(4 H )-thione bearing salicylate moiety: synthesis and evaluation as anti- Candida albicans
|
Autores: |
Radwan,Awwad Abdoh
Alanazi,Fares Kaed
Al-Agamy,Mohammed Hamed
|
Data: |
2017-01-01
|
Ano: |
2017
|
Palavras-chave: |
Anti-Candida/docking studies
Thiadiazole
Triazole
|
Resumo: |
Abstract Dramatically increased occurrence of both superficial and invasive fungal infections has been observed. Candida albicans appear to be the main etiological agent of invasive fungal infections. The anti-C. albicans activity of thiosemicarbazide, 1,3,4-Thiadiazole, and 1,2,4-triazole-3(4H)-thione compounds (compounds 3-23) were investigated. The MIC values of thiadiazole and triazole derivatives 10-23 were in the range of 0.08-0.17 µmol mL-1, while that of fluconazole was 0.052 µmol mL-1. Compound 11 (5-(2-(4-chlorobenzyloxy)phenyl)-N-allyl-1,3,4-thiadiazol-2-amine) and compound 18 (5-(2-(4-chlorobenzyloxy)phenyl)-4-allyl-2H-1,2,4-triazole-3(4H)-thione) were found to be the most active compounds, with MIC values of 0.08 µmol mL-1. The newly synthesized thiadiazole and triazole compounds (compounds 10-23) showed promising anti-Candida activity. The allyl substituent-bearing compounds 11 and 18 exhibited significant anti-Candida albicans activity and showed a binding mode as well as the fluconazole x-ray structure.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000100614
|
Editor: |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
|
Relação: |
10.1590/s2175-97902017000115239
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Pharmaceutical Sciences v.53 n.1 2017
|
Direitos: |
info:eu-repo/semantics/openAccess
|
|